ImmunoPrecise Antibodies Ltd. Files 6-K with Press Release
Ticker: HYFT · Form: 6-K · Filed: Mar 13, 2025 · CIK: 1715925
Sentiment: neutral
Topics: filing-update, press-release, sec-filing
TL;DR
IPA files 6-K, includes March 13 press release. Check for updates.
AI Summary
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on March 13, 2025, incorporating a press release dated March 13, 2025, as Exhibit 99.1. This filing is related to their ongoing reporting requirements and incorporates information into existing registration statements on Form S-8 and Form F-3.
Why It Matters
This filing serves as an update and incorporates a press release, which may contain material information for investors regarding the company's operations or strategic developments.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily incorporates a press release and updates existing registration statements, with no immediate indication of significant new risks.
Key Numbers
- 001-39530 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- ImmunoPrecise Antibodies Ltd. (company) — Registrant
- March 13, 2025 (date) — Press Release Date
- 001-39530 (company) — SEC File Number
- 333-256730 (company) — Form S-8 Registration Statement File Number
- 333-273197 (company) — Form F-3 Registration Statement File Number
- 333-281312 (company) — Form F-3 Registration Statement File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report information under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, specifically incorporating a press release dated March 13, 2025, as Exhibit 99.1.
Which registration statements does this filing incorporate information into?
This filing incorporates Exhibit 99.1 into the Registration Statement on Form S-8 (File No. 333-256730) and Registration Statements on Form F-3 (File Nos. 333-273197 and 333-281312).
What is the filing date of this Form 6-K?
The filing date is March 13, 2025.
What is the company's principal executive office address listed in the filing?
The principal executive office is located at Industrious, 823 Congress Ave Suite 300, Austin, Texas 78701.
What is the SIC code for ImmunoPrecise Antibodies Ltd.?
The Standard Industrial Classification (SIC) code for ImmunoPrecise Antibodies Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 13, 2025 regarding ImmunoPrecise Antibodies Ltd. (HYFT).